영국의 수술용 플레짓 시장(2025-2033년)

The U.K. surgical pledgets market reached US$ 13.50 million in 2024 and is expected to reach US$ 20.90 million by 2033, growing at a CAGR of 5.4 % during the forecast period 2025-2033.

Surgical pledgets are specialized medical devices utilized in surgical procedures to improve the effectiveness of sutures. They are non-absorbable synthetic patches primarily constructed from polytetrafluoroethylene (PTFE). These patches are typically small, flat, and resilient and are designed to be placed beneath sutures during surgical interventions.

The main purpose of surgical pledgets is to serve as suture supports. When sutures are applied to delicate tissues, there is a risk that the tension exerted by the sutures may cause tearing or damage to the surrounding tissue. Pledgets help alleviate this risk by distributing the tension of the sutures over a wider area. This broader distribution reduces localized pressure on the tissue, thereby protecting it from strain and potential injury. These factors have driven the U.K. surgical pledgets market expansion.

Market Dynamics: Drivers & Restraints

Advancements in Surgical Technologies

Advancements in surgical technologies are a crucial driver of growth in the U.K. surgical pledgets market, significantly enhancing their effectiveness, safety, and application. Recent innovations in materials science have led to the development of advanced synthetic materials for surgical pledgets, such as polytetrafluoroethylene (PTFE) and other biocompatible polymers. These materials exhibit low tissue reactivity and high durability, making them ideal for surgical applications.

Modern surgical environments are increasingly incorporating technologies such as robotic-assisted surgery and enhanced imaging systems. Surgical pledgets are being designed to integrate seamlessly with these systems, allowing for more precise placement and improved outcomes. This technological integration enhances the overall efficacy of surgical procedures. All these factors demand the U.K. surgical pledgets market. Moreover, the growing demand for minimally invasive surgeries contributes to the U.K. surgical pledgets market expansion.

High Cost of Surgical Pledgets

The high cost of surgical pledgets is a significant constraint in the U.K. surgical pledgets market, impacting both healthcare providers and patients. The substantial price of surgical pledgets presents a financial challenge for hospitals and surgical centers, especially those operating with limited budgets. When confronted with high costs, these facilities may prioritize essential medical supplies over specialized items like pledgets, potentially affecting their availability during surgeries.

Elevated costs can restrict patient access to necessary surgical procedures. If healthcare facilities are unable to absorb these expenses, they may pass them on to patients, making surgeries less affordable. This financial barrier can deter patients from seeking timely surgical interventions, leading to delays in treatment and worsening health outcomes.

The high cost of surgical pledgets may lead healthcare providers to consider alternative wound closure methods, such as surgical staplers or adhesive strips, which are perceived as more cost-effective options. This shift in preference could hinder the growth of the surgical pledgets market as providers opt for alternatives that better fit their budget constraints. Thus, the above factors could be limiting the U.K. surgical pledgets market's potential growth.

Segment Analysis

The U.K. surgical pledgets market is segmented based on type, material, application, end-user, and region.

Type:

The non-absorbable pledgets segment is expected to dominate the U.K. surgical pledgets market share

The non-absorbable pledgets segment holds a major portion of the U.K. surgical pledgets market share and is expected to continue to hold a significant portion of the U.K. surgical pledgets market share during the forecast period.

Non-absorbable pledgets are synthetic devices specifically designed to provide reinforcement and support to sutured tissues during surgical procedures. They are primarily made from materials such as Polytetrafluoroethylene (PTFE) known for their exceptional durability, low friction, and minimal tissue reactivity, making them suitable for long-term applications. Polyester is valued for its strength and compatibility with various surgical techniques. These materials are selected for their ability to withstand biological environments without degrading, ensuring their effectiveness throughout the healing process.

Non-absorbable pledgets hold a significant share of the U.K. surgical pledgets market due to their widespread adoption across various surgical specialties. Their durability and low risk of complications contribute to their popularity among healthcare providers.

Non-absorbable pledgets are utilized in several key areas of cardiac surgery they provide essential support during procedures such as aortic valve replacements and coronary artery bypass grafts, where maintaining suture integrity is critical. Thoracic surgery is used to reinforce sutures in lung surgeries, ensuring stability and minimizing complications. General surgery is employed in diverse surgical procedures to enhance suture performance and reduce tissue damage.

The increasing prevalence of cardiovascular diseases among the aging population in the U.K. is driving demand for non-absorbable pledgets. As the geriatric demographic expands, so does the need for surgical interventions that utilize these devices. Innovations in material science are leading to the development of more effective non-absorbable pledget designs, enhancing their performance and broadening their applications across different surgical specialties. These factors have solidified the segment's position in the U.K. surgical pledgets market.

Competitive Landscape

The major players in the U.S. pollinosis market include Medtronic, B. Braun SE, Johnson & Johnson (Ethicon), Teleflex Incorporated., PetersSurgical, DeRoyal Industries, Inc., BD, Boz Medical, Advanced MedTech Solutions Pvt. Ltd, and Golnit among others.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The U.K. surgical pledgets market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Type
• 3.2. Snippet by Material
• 3.3. Snippet by Application
• 3.4. Snippet by End-User
• 3.5. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Advancements in Surgical Technologies
  • 4.1.2. Restraints
    • 4.1.2.1. High Cost of Surgical Pledgets
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Patent Analysis
• 5.5. Regulatory Analysis
• 5.6. SWOT Analysis
• 5.7. Unmet Needs

6. By Type

• 6.1. Introduction
  • 6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Type
  • 6.1.2. Market Attractiveness Index, By Type
• 6.2. Non-Absorbable Pledgets*
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 6.3. Absorbable Pledgets

7. By Material

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
  • 7.1.2. Market Attractiveness Index, By Material
• 7.2. Polytetrafluoroethylene (PTFE)*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Polypropylene
• 7.4. Dacron
• 7.5. Others

8. By Application

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 8.1.2. Market Attractiveness Index, By Application
• 8.2. Cardiac Surgery*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Thoracic Surgery
• 8.4. General Surgery
• 8.5. Others

9. By End-User

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 9.1.2. Market Attractiveness Index, By End-User
• 9.2. Hospitals*
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 9.3. Specialty Clinics
• 9.4. Ambulatory Surgical Centers (ASCs)
• 9.5. Others

10. Competitive Landscape

• 10.1. Competitive Scenario
• 10.2. Market Positioning/Share Analysis
• 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

• 11.1. Medtronic *
  • 11.1.1. Company Overview
  • 11.1.2. Product Portfolio
    • 11.1.2.1. Product Description
    • 11.1.2.2. Product Key Performance Indicators (KPIs)
    • 11.1.2.3. Historic and Forecasted Product Sales
    • 11.1.2.4. Product Sales Volume
  • 11.1.3. Financial Overview
    • 11.1.3.1. Company Revenue's
    • 11.1.3.2. Geographical Revenue Shares
    • 11.1.3.3. Revenue Forecasts
  • 11.1.4. Key Developments
    • 11.1.4.1. Mergers & Acquisitions
    • 11.1.4.2. Key Product Development Activities
    • 11.1.4.3. Regulatory Approvals etc.
  • 11.1.5. SWOT Analysis
• 11.2. B. Braun SE
• 11.3. Johnson & Johnson (Ethicon)
• 11.4. Teleflex Incorporated.
• 11.5. PetersSurgical
• 11.6. DeRoyal Industries, Inc.
• 11.7. BD
• 11.8. Boz Medical
• 11.9. Advanced MedTech Solutions Pvt. Ltd
• 11.10. Golnit

LIST NOT EXHAUSTIVE

12. Appendix

• 12.1. About Us and Services
• 12.2. Contact Us